Effect of oral esomeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 1, 2007, Pages 43-46

  Wei, Kou Liang ^a   Tung, Shui Yi ^a,b   Sheen, Cheng Han ^a   Chang, Te Shen ^a   Lee, I Lin ^a   Wu, Cheng Shyong ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Endoscopic therapy; Peptic ulcer; Proton pump inhibitor; Upper gastrointestinal bleeding

Indexed keywords

ADRENALIN; ESOMEPRAZOLE; LANSOMEPRAZOLE; OMEPRAZOLE DERIVATIVE;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDOSCOPIC THERAPY; FEMALE; HEMOSTASIS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; THERMOCOAGULATION; UPPER GASTROINTESTINAL BLEEDING;

EID: 33845624202     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04354.x     Document Type: Article

References (24)

1. Gilbert DA. Epidemiology of upper gastrointestinal bleeding. Gastrointest. Endosc. 1990; 36(Suppl.): S8-13.
2. Cook DJ, Guyatt GH, Salena BJ, Laine LA. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology 1992; 102: 139-48.
3. Consensus Conference. Therapeutic endoscopy and bleeding ulcers. JAMA 1989; 262: 1369-72.
4. Sacks HS, Chalmers TC, Blum AL, Berrier J, Pagano D. Endoscopic hemostasis: an effective therapy for bleeding peptic ulcers. JAMA 1990; 264: 494-9.
5. Cheng HC, Chuang SA, Kao YH, Kao AW, Chuang CH, Sheu BS. Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion. Hepatogastroenterology 2003; 50: 2270-3.
6. Lau JY, Sung JJ, Lee KK et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N. Engl. J. Med. 2000; 343: 310-16.
7. Lin HJ, Lo WC, Lee FY, Perng CL, Tseng GY. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch. J. Med. 1998; 158: 54-8.
8. Schaffalitzky DE, Muckadell OB, Havelund T et al. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers: randomized double-blind placebo-controlled multicentre study. Scand. J. Gastroenterol. 1997; 32: 320-7.
9. Khuroo MS, Yattoo GN, Javid G et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N. Engl. J. Med. 1997; 336: 1054-8.
10. Jung HK, Son HY, Jung SA et al. Comparison of oral omeprazole and endoscopic ethanol injection therapy for prevention of recurrent bleeding from peptic ulcers with nonbleeding visible vessels or fresh adherent clots. Am. J. Gastroenterol. 2002; 97: 1736-40.
11. Green FW, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation. Gastroenterology 1978; 74: 38-43.
12. Li Y, Sha W, Nie Y et al. Effect of intragastric PH on control peptic ulcer bleeding. J. Gastroenterol. Hepatol. 2000; 15: 148-54.
13. Labenz J, Peitz U, Leusing C, Tillenburg B, Blum AL, Borsch G. Efficacy of primed infusion with high dose ranitidine and omeprazole to maintain high intragastric PH in patients with peptic ulcer bleeding: a prospective randomized controlled study. Gut 1997; 40: 36-41.
14. Lanas A, Artal A, Blas JM, Arroyo MT, Lopez-Zaborras J, Sainz R. Effect of parenteral omeprazole and ranitidine on gastric PH and the outcome of bleeding peptic ulcer. J. Clin. Gastroenterol. 1995; 21: 103-6.
15. Lin HJ, Lo WC, Perng CL, Wang K, Lee FY. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with nonbleeding visible vessel: a preliminary report of a randomized comparative study. Hepatogastroenterology 1997; 44: 1495-9.
16. Sung JJ, Chan FK, Lau JY et al. The effect of endoscopic therapy in patients receiving omepazole for bleeding peptic ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison. Ann. Intern. Med. 2003; 139: 237-43.
17. Bleau BL, Gostout CJ, Sherman KE et al. Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointest. Endosc. 2002; 56: 1-6.
18. Janssen DM. Treatment of patients at high risk for recurrent bleeding from a peptic ulcer. Ann. Intern. Med. 2003; 139: 294-5.
19. Jensen DM, Kovacs TO, Jutabha R et al. Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots. Gastroenterology 2002; 123: 403-13.
20. Bustamante M, Stollman N. The efficacy of proton-pump inhibitors in acute ulcer bleeding: a qualitative review. J. Clin. Gastroenterol. 2000; 30: 7-13.
21. Lindberg P, Keeling D, Fryklund J, Andersson T, Lundborg P, Carlsson E. Esomeprazole-enhanced bio-availability, specificity for the proton pump and inhibition of acid secretion. Aliment. Pharmacol. Ther. 2003; 17: 481-8.
22. Lau YW, Sung JY. Management options for patients with ulcer hemorrhage. Ann. Intern. Med. 2004; 140: 845-6.
23. Javid G, Masoodi I, Zargar SA et al. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am. J. Med. 2001; 111: 280-4.
24. Kaviani MJ, Hashemi MR, Kazemifar AR et al. Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective, double-blind, randomized, clinical trial. Aliment. Pharmacol. Ther. 2003; 17: 211-16.